"It'll be incumbent upon us to make sure that we're able to demonstrate differentiation," Abridge CEO Dr. Shiv Rao told CNBC. "So far, we've had good luck these last few years doing that."
Abridge has deployed its technology across more than 100 health systems in the U.S., including organizations like the Mayo Clinic, Duke Health and Johns Hopkins Medicine.
The company announced a $250 million funding round earlier this month. It also unveiled a new Contextual Reasoning Engine that can pull information that's relevant to a specific clinician and their clinic's best practices. Abridge's Rao said that technology will be available to Athenahealth clinicians.